36 results on '"Uzelac, Zeljko"'
Search Results
2. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
3. Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen – a monocenter observational study
4. Pattern of pareses in 5q-spinal muscular atrophy.
5. Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi
6. Staged treatment response in Status epilepticus ‐ Lessons from the SENSE registry
7. Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)
8. Sustained Effort Network for treatment of Status Epilepticus (SENSE) – A multicenter prospective observational registry
9. Staged treatment response in status epilepticus: Lessons from the SENSE registry.
10. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients
11. Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis
12. Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy
13. Refractory Status Epilepticus: Risk Factors and Analysis of Intubation in the Multicenter SENSE Registry
14. Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy
15. Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania
16. Quality of Life in SMA Patients Under Treatment With Nusinersen
17. Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)
18. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism
19. Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
20. Refractory Status Epilepticus
21. Quality of Life in SMA Patients Under Treatment With Nusinersen
22. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.44
23. Factors predicting cessation of status epilepticus in clinical practice – data from a prospective observational registry (SENSE)
24. Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
25. Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE)
26. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment
27. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients
28. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
29. SENSE registry for status epilepticus
30. Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data
31. Making SENSE - Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry
32. Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity
33. Unifying Concept of Serotonin Transporter-associated Currents
34. The Large Extracellular Loop of Organic Cation Transporter 1 Influences Substrate Affinity and Is Pivotal for Oligomerization
35. The Plasma Membrane-Associated GTPase Rin Interacts with the Dopamine Transporter and Is Required for Protein Kinase C-Regulated Dopamine Transporter Trafficking
36. Lithium Stabilizes the Inward Facing Conformation of Human Serotonin Transporter (hSERT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.